Listed

MACOM Technology Solutions Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2023

Filed with the SEC on Aug 3, 2023 and accepted by EDGAR at Aug 3, 2023, 16:01 ET.

Share

Management's discussion and analysis

As filed, 30,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended September 30, 2022 filed with the United States Securities and Exchange Commission (“SEC”) on November 14, 2022 (the “2022 Annual Report on Form 10-K”).

In this document, the words “Company,” “we,” “our,” “us,” and similar terms refer only to MACOM Technology Solutions Holdings, Inc. and its consolidated subsidiaries, and not any other person or entity.

“MACOM,” “MACOM Technology Solutions,” and related logos are trademarks of MACOM Technology Solutions Holdings, Inc. All other brands and names listed are trademarks of their respective owners.

Cautionary Note Regarding Forward-Looking Statements

This Item 2, “Management's Discussion and Analysis of Financial Condition and Results of Operations” and other sections of this Quarterly Report on Form 10-Q contain “forward-looking statements.” In addition, we may make other written and oral communications from time to time that contain such statements. Forward-looking statements include statements regarding our business outlook, strategic plans and priorities, expectations, anticipated drivers of future revenue growth, our ability to better address certain markets, expand our capabilities and extend our product offerings through the Linearizer Acquisition and the MESC Acquisition, industry trends, the potential impacts of COVID-19 on our future operations and results, our estimated annual effective tax rate, our plans for use of our cash and cash equivalents and short-term investments, interest rate and foreign currency risks, our ability to meet working capital requirements, estimates and objectives for future operations, our future results of operations and our financial position, including liquidity, and other matters that do not relate strictly to historical facts. Forward-looking statements generally may be identified by terms such as “anticipates,” “believes,” “could,” “continue,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “targets,” “will,” “would” or similar expressions or variations or the negatives of those terms. These statements are based on management's beliefs and assumptions as of the date of this Quarterly Report on Form 10-Q, based on information currently available to us. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from the forward-looking statements include, among others, the risks described in the section entitled “Risk Factors” in this Quarterly Report on Form 10-Q and the 2022 Annual Report on Form 10-K. We caution the reader to carefully consider such factors. Furthermore, such forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

We design and manufacture semiconductor products for Telecommunications (“Telecom”), Industrial and Defense (“I&D”) and Data Center industries. Headquartered in Lowell, Massachusetts, with operational facilities throughout North America, Europe and Asia, we design, develop and manufacture differentiated semiconductor products for customers who demand high performance, quality and reliability. We have more than 70 years of application expertise, combined with expertise in analog and mixed signal circuit design, compound semiconductor fabrication (including gallium arsenide, gallium nitride, indium phosphide and specialized silicon), advanced packaging and back-end assembly and test. We offer a broad portfolio of thousands of standard and custom devices, which include integrated circuits (“IC”), multi-chip modules, diodes, amplifiers, switches and switch limiters, passive and active components and complete subsystems, across dozens of product lines serving over 6,000 end customers in three primary markets. Our semiconductor products are electronic components that our customers generally incorporate into larger electronic systems, such as wireless communication systems including basestations, high capacity optical networks, data center applications, radar, medical systems and test and measurement applications. Our primary end markets are: (1) Telecom, which includes carrier infrastructure such as long-haul/metro, 5G and Fiber-to-the-X/passive optical network, among others; (2) I&D, which includes military and commercial radar, radio frequency (“RF”) jammers, electronic countermeasures, communication data links, satellite communications and multi-market applications, which include industrial, medical, test and measurement and scientific applications; and (3) Data Center, which includes intra-Data Center, Data Center Interconnect applications, at 100G, 200G, 400G, 800G and higher speeds, enabled by our broad portfolio of analog ICs and photonic components for high speed optical module customers.

COVID-19 Impact

As a result of the numerous government and related measures that have been implemented around the world where we operate to address COVID-19 and the spread of COVID-19, we have modified our business practices and may further modify our practices as required, or as we determine appropriate. While these measures, as well as other disruptions, have impacted our operations, the operations of our customers and those of our respective vendors and suppliers, such impacts did not, through the nine months ended June 30, 2023, have a material impact on our consolidated operating results. However, the degree to which COVID-19 may impact our business, financial condition, results of operations, liquidity and cash flows will continue to depend on future developments, which remain highly uncertain and cannot be predicted.

For additional information on risk factors that could impact our future results, please refer to the section entitled “Risk Factors” in this Quarterly Report on Form 10-Q and the 2022 Annual Report on Form 10-K.

Description of Our Revenue

Revenue. Our revenue is derived from sales of high-performance RF, microwave, millimeter wave, optical and photonic semiconductor products. We design, integrate, manufacture and package differentiated, semiconductor-based products that we sell to customers through our direct sales organization, our network of independent sales representatives and our distributors.

We believe the primary drivers of our future revenue growth will include:

  • continued growth in the demand for high-performance analog, digital and optical semiconductors in our three primary markets;
  • introducing new products using advanced technologies, added features, higher levels of integration and improved performance;
  • increasing content of our semiconductor solutions in customers’ systems through cross-selling our product lines;
  • leveraging our core strength and leadership position in standard, catalog products that service all of our end applications; and
  • engaging early with our lead customers to develop custom and standard products.

Our core strategy is to develop and innovate high-performance products that address our customers’ most difficult technical challenges in our primary markets: Telecom, I&D and Data Center.

We expect our revenue in the Telecom market to be driven by 5G deployments, with continued upgrades and expansion of communications equipment, and increasing adoption of our high-performance RF, millimeter wave, optical and photonic components.

We expect our revenue in the I&D market to be driven by the expanding product portfolio that we offer which services applications such as test and measurement, satellite communications, civil and military radar, industrial, automotive, scientific and medical applications, further supported by growth in applications for our multi-market catalog products.

We expect our revenue in the Data Center market to be driven by the adoption of cloud-based services and the upgrade of data center architectures to 100G, 200G, 400G and 800G interconnects, which we expect will drive adoption of higher speed optical and photonic components.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements. The preparation of financial statements, in conformity with GAAP, requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, the reported amounts of revenue and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty and could be material if our actual or expected experience were to change unexpectedly. On an ongoing basis, we re-evaluate our estimates and judgments.

We base our estimates and judgments on our historical experience and on other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making the judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates and material effects on our operating results and financial position may result. The accounting policies which our management believes involve the most significant application of judgment or involve complex estimation, are inventories and associated reserves; revenue reserves; goodwill and intangible asset valuation; share-based compensation valuations and income taxes.

Significant management judgment is required in our valuation of goodwill and intangible assets, many of which are based on the creation of forecasts of future operating results that are used in the valuation, including (i) estimation of future cash flows, (ii) estimation of the long-term rate of growth for our business, (iii) estimation of the useful life over which cash flows will occur, (iv) terminal values, if applicable and (v) the determination of our weighted average cost of capital, which helps determine the discount rate. It is possible that these forecasts may change, and our performance projections included in our forecasts of future results may prove to be inaccurate. The value of our goodwill and purchased intangible assets could also be impacted by future adverse changes such as a decline in the valuation of technology company stocks, including the valuation of our common stock, or a significant slowdown in the worldwide economy or in the optical communications equipment or semiconductor industry.

For additional information related to these and other accounting policies refer to Note 2 - Summary of Significant Accounting Policies to our Consolidated Financial Statements included in Item 8 of Part II, “Financial Statements and Supplementary Data,” of the 2022 Annual Report on Form 10-K and Note 1 - Basis of Presentation and Summary of Significant Accounting Policies to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Results of Operations

The following table sets forth, for the periods indicated, our statements of operations data (in thousands):

Three Months Ended June 30, 2023 July 1, 2022 Nine Months Ended June 30, 2023 July 1, 2022
Revenue $148,522 $172,259 $498,032 $497,027
Cost of revenue (1) 62,396 67,717 198,861 199,353
Gross profit 86,126 104,542 299,171 297,674
Operating expenses:
Research and development (1) 36,668 37,625 111,037 108,550
Selling, general and administrative (1) 32,152 30,914 96,341 93,481
Total operating expenses 68,820 68,539 207,378 202,031
Income from operations 17,306 36,003 91,793 95,643
Other income (expense):
Interest income (expense), net 2,344 (845) 4,580 (3,928)
Other (expense) income, net (2) (29) 13 (207) 114,866
Total other income (expense), net 2,315 (832) 4,373 110,938
Income before income taxes 19,621 35,171 96,166 206,581
Income tax expense 7,768 2,937 29,039 5,962
Net income $11,853 $32,234 $67,127 $200,619

(1) Includes (a) Amortization expense related to intangible assets arising from acquisitions and (b) Share-based compensation expense included in our condensed consolidated statements of operations as set forth below (in thousands):

(a) Intangible amortization expense: Three Months Ended June 30, 2023 July 1, 2022 Nine Months Ended June 30, 2023 July 1, 2022
Cost of revenue $1,131 $1,779 $3,028 $6,062
Selling, general and administrative 5,976 6,276 17,644 19,334
(b) Share-based compensation expense:
Cost of revenue $1,078 $929 $3,239 $3,035
Research and development 3,281 3,709 11,255 10,818
Selling, general and administrative 3,903 5,707 14,275 16,407

(2) The nine months ended July 1, 2022 includes a gain on the sale of our equity method investment of $118.2 million and net losses of $3.3 million associated with such equity method investment. See Note 4 - Investments to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information.

The following table sets forth, for the periods indicated, our statements of operations data expressed as a percentage of our revenue:

Three Months Ended June 30, 2023 July 1, 2022 Nine Months Ended June 30, 2023 July 1, 2022
Revenue 100.0% 100.0% 100.0% 100.0%
Cost of revenue 42.0 39.3 39.9 40.1
Gross profit 58.0 60.7 60.1 59.9
Operating expenses:
Research and development 24.7 21.8 22.3 21.8
Selling, general and administrative 21.6 17.9 19.3 18.8
Total operating expenses 46.3 39.8 41.6 40.6
Income from operations 11.7 20.9 18.4 19.2
Other income (expense):
Interest income (expense), net 1.6 (0.5) 0.9 (0.8)
Other (expense) income, net 0.0 — 0.0 23.1
Total other income (expense), net 1.6 (0.5) 0.9 22.3
Income before income taxes 13.2 20.4 19.3 41.6
Income tax expense 5.2 1.7 5.8 1.2
Net income 8.0% 18.7% 13.5% 40.4%

Comparison of the Three and Nine Months Ended June 30, 2023 to the Three and Nine Months Ended July 1, 2022

Revenue. Our revenue decreased by $23.7 million, or 13.8%, to $148.5 million for the three months ended June 30, 2023, from $172.3 million for the three months ended July 1, 2022, and our revenue increased by $1.0 million, or 0.2%, to $498.0 million for the nine months ended June 30, 2023, from $497.0 million for the nine months ended July 1, 2022. The decrease in revenue in the three months ended June 30, 2023 and increase in revenue in the nine months ended June 30, 2023 is described by end market in the following paragraphs.

Revenue from our primary markets, the percentage of change between the periods presented, and revenue by primary markets expressed as a percentage of total revenue in the periods presented were (in thousands, except percentages):

Three Months Ended June 30, 2023 July 1, 2022 % Change Nine Months Ended June 30, 2023 July 1, 2022 % Change
Telecom $38,333 $61,988 (38.2)% $153,670 $180,738 (15.0)%
Industrial & Defense 83,549 75,509 10.6% 237,911 215,794 10.2%
Data Center 26,640 34,762 (23.4)% 106,451 100,495 5.9%
Total $148,522 $172,259 (13.8)% $498,032 $497,027 0.2%
Telecom 25.8% 36.0% 30.9% 36.4%
Industrial & Defense 56.3% 43.8% 47.8% 43.4%
Data Center 17.9% 20.2% 21.3% 20.2%
Total 100.0% 100.0% 100.0% 100.0%

In the three months ended June 30, 2023, our Telecom market revenue decreased by $23.7 million, or 38.2%, compared to the three months ended July 1, 2022. In the nine months ended June 30, 2023, our Telecom market revenue decreased by $27.1 million, or 15.0%, compared to the nine months ended July 1, 2022. The decrease for the three and nine months ended June 30, 2023 was primarily driven by a decrease in sales of products targeted for 5G applications, a decrease in sales of carrier-based optical semiconductor products, a decrease in sales of RF and microwave products for broadband access and video infrastructure and a decrease in sales of legacy backhaul products, primarily in China.

In the three months ended June 30, 2023, our I&D market revenue increased by $8.0 million, or 10.6%, compared to the three months ended July 1, 2022. In the nine months ended June 30, 2023, our I&D market revenue increased by $22.1 million, or 10.2%, compared to the nine months ended July 1, 2022. The increase in the three and nine months ended June 30, 2023 was primarily driven by defense program shipments, which includes incremental revenue from recent acquisitions, and expansion of high-performance analog product lines into the I&D market.

In the three months ended June 30, 2023, our Data Center market revenue decreased by $8.1 million, or 23.4%, compared to the three months ended July 1, 2022. In the nine months ended June 30, 2023, our Data Center market revenue increased by $6.0 million, or 5.9%, compared to the nine months ended July 1, 2022. The decrease in the three months ended June 30, 2023 was primarily driven by a decrease in sales of high-performance analog Data Center products. The increase in the nine months ended June 30, 2023 was primarily driven by an increase in sales of our legacy connectivity products, which were supply constrained in prior periods, partially offset by a decrease in sales of optical semiconductor products and high-performance analog Data Center products.

We continue to be negatively impacted by the current macroeconomic conditions, which we expect may result in weaker near-term demand for our products.

Gross profit. Gross margin was 58.0% and 60.7% for the three months ended June 30, 2023 and July 1, 2022, respectively, and 60.1% and 59.9% for the nine months ended June 30, 2023 and July 1, 2022, respectively. Gross profit was $86.1 million and $104.5 million for the three months ended June 30, 2023 and July 1, 2022, respectively, and $299.2 million and $297.7 million for the nine months ended June 30, 2023 and July 1, 2022, respectively. Gross profit decreased for the three months ended June 30, 2023 as compared to the three months ended July 1, 2022 primarily as a result of lower sales, increases in production supplies, employee headcount, employee-related costs and variable costs, partially offset by lower intangible amortization. Gross profit increased for the nine months ended June 30, 2023 as compared to the nine months ended July 1, 2022 primarily as a result of higher sales and lower intangible amortization, partially offset by increases in production supplies, employee headcount primarily due to acquisitions, employee-related costs, depreciation expense and variable costs.

Research and development. Research and development expense decreased by $1.0 million, or 2.5%, to $36.7 million, or 24.7% of our revenue, for the three months ended June 30, 2023, compared to $37.6 million, or 21.8% of our revenue, for the three months ended July 1, 2022. Research and development expense increased by $2.5 million, or 2.3%, to $111.0 million, or 22.3% of our revenue, for the nine months ended June 30, 2023, compared to $108.6 million, or 21.8% of our revenue, for the nine months ended July 1, 2022. Research and development expense decreased in the three months ended June 30, 2023 primarily as a result of lower supply costs and design software costs, partially offset by increases in employee-related costs. Research and development expense increased in the nine months ended June 30, 2023 primarily as a result of increases in employee headcount primarily due to acquisitions, employee-related costs and development foundry costs, partially offset by decreases in design software costs and depreciation expense.

Selling, general and administrative. Selling, general and administrative expense increased by $1.2 million, or 4.0%, to $32.2 million, or 21.6% of our revenue, for the three months ended June 30, 2023, compared to $30.9 million, or 17.9% of our revenue, for the three months ended July 1, 2022. Selling, general and administrative expense increased by $2.9 million, or 3.1%, to $96.3 million, or 19.3% of our revenue, for the nine months ended June 30, 2023, compared to $93.5 million, or 18.8% of our revenue, for the nine months ended July 1, 2022. Selling, general and administrative expense increased in the three and nine months ended June 30, 2023 primarily due to an increase in acquisition-related professional fees, employee headcount and travel expense, partially offset by decreases in employee-related costs, share-based compensation expense and intangible amortization.

Interest income (expense), net. In the three months ended June 30, 2023, interest income, net was $2.3 million, compared to interest expense, net of $0.8 million for the three months ended July 1, 2022. In the nine months ended June 30, 2023, interest income, net was $4.6 million, compared to interest expense, net of $3.9 million for the nine months ended July 1, 2022. The change for the three and nine months ended June 30, 2023 is primarily due to an increase in short-term investments and associated interest income, partially offset by an increase in interest expense on the Term Loans.

Provision for income taxes. Our income tax expense and effective income tax rates for the periods indicated were (in thousands, except percentages):

Three Months Ended June 30, 2023 July 1, 2022 Nine Months Ended June 30, 2023 July 1, 2022
Income tax expense 7,768 2,937 29,039 5,962
Effective income tax rate 39.6% 8.4% 30.2% 2.9%

The difference between the U.S. federal statutory income tax rate of 21% and our effective income tax rate for the three and nine months ended June 30, 2023, was primarily driven by tax on GILTI including changes to Section 174 requiring the capitalization of certain R&D expenses, resulting in a 16% increase from the statutory income tax rate for both periods, non-deductible compensation and state income taxes partially offset by income taxed in foreign jurisdictions generally at lower tax rates and R&D tax credits. Our effective income tax rate for the three and nine months ended July 1, 2022 was primarily driven by the full valuation allowance against any expense associated with income in the U.S. and income taxed in foreign jurisdictions generally at lower tax rates, where a valuation allowance does not apply. Our estimated annual effective tax rate for the year ending September 29, 2023 is expected to be approximately 30%, adjusted for discrete taxation matters arising during the interim periods.

For additional information refer to Note 14 - Income Taxes to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Liquidity and Capital Resources

The following table summarizes our cash flow activities (in thousands):

Nine Months Ended June 30, 2023 July 1, 2022
Cash and cash equivalents, beginning of period $119,952 $156,537
Net cash provided by operating activities 116,563 116,989
Net cash used in investing activities (87,361) (111,809)
Net cash used in financing activities (27,795) (28,609)
Foreign currency effect on cash 161 (938)
Cash and cash equivalents, end of period $121,520 $132,170

Cash Flow from Operating Activities

Our cash flow from operating activities for the nine months ended June 30, 2023 of $116.6 million consisted of a net income of $67.1 million plus adjustments of $89.3 million, to reconcile our net income to cash provided by operating activities, less cash used in operating assets and liabilities of $39.9 million. Adjustments to reconcile our net income to cash provided by operating activities primarily included depreciation and intangible amortization expense of $38.4 million, share-based compensation expense of $28.8 million, deferred income tax expense of $27.4 million. In addition, cash used in operating assets and liabilities was $39.9 million for the nine months ended June 30, 2023, primarily driven by an increase in inventories of $12.2 million and a decrease of $16.6 million in accrued and other liabilities.

Our cash flow from operating activities for the nine months ended July 1, 2022 of $117.0 million consisted of a net income of $200.6 million, less adjustments of $38.3 million, to reconcile our net income to cash provided by operating activities and cash used in operating assets and liabilities of $45.3 million. Adjustments to reconcile our net income to cash provided by operating activities primarily included a net gain of $114.9 million related to the sale of our equity method investment offset by equity method investment losses, depreciation and intangible amortization expense of $43.1 million and share-based compensation expense of $30.3 million. In addition, cash used in operating assets and liabilities was $45.3 million for the nine months ended July 1, 2022, primarily driven by an increase in accounts receivable of $22.0 million, an increase in inventories of $27.5 million and a decrease of $12.7 million in accrued and other liabilities, partially offset by an increase in accounts payable of $14.1 million.

Cash Flow from Investing Activities

Our cash flow used in investing activities for the nine months ended June 30, 2023 of $87.4 million consisted primarily of $87.7 million for acquisitions, net of cash acquired, capital expenditures of $18.9 million and purchases of $352.9 million of short-term investments, offset by proceeds of $364.1 million for the sale and maturity of short-term investments and proceeds from the sale of equipment of $8.0 million. For additional information on the cash paid for our acquisitions, net of cash acquired, see Note 3 - Acquisitions to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Our cash flow used in investing activities for the nine months ended July 1, 2022 of $111.8 million consisted primarily of purchases of $386.8 million of short-term investments and capital expenditures of $18.8 million, offset by proceeds from the sale of our equity method investment of $127.8 million and proceeds of $166.0 million for the sale and maturity of short-term investments. For additional information on the sale of our equity method investment, see Note 4 - Investments to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Cash Flow from Financing Activities

During the nine months ended June 30, 2023, our cash used in financing activities of $27.8 million was primarily related to $32.5 million of repurchases of common stock associated with employee tax withholdings on vested equity awards, partially offset by $5.6 million of proceeds from employee stock purchases.

During the nine months ended July 1, 2022, our cash used in financing activities of $28.6 million was primarily related to $35.9 million of repurchases of common stock associated with employee tax withholdings on vested equity awards, partially offset by $8.1 million of proceeds from stock option exercises and employee stock purchases.

Liquidity

As of June 30, 2023, we held $121.5 million of cash and cash equivalents, primarily deposited with financial institutions, as well as $466.1 million of liquid short-term investments. The undistributed earnings of certain foreign subsidiaries are considered indefinitely reinvested for the periods presented and we do not intend to repatriate such earnings. We believe the decision to reinvest these earnings will not have a significant impact on our liquidity. As of June 30, 2023, cash held by our indefinitely reinvested foreign subsidiaries was $20.8 million, which, along with cash generated from foreign operations, is expected to be used in the support of international growth and working capital requirements as well as the repayment of certain intercompany loans.

On August 2, 2023, we paid the total outstanding principal balance on our Term Loans of $120.8 million and accrued interest of less than $0.1 million with cash-on-hand.

We plan to use our remaining available cash and cash equivalents and short-term investments for general corporate purposes, including working capital, or for the acquisition of or investment in complementary technologies, design teams, products and businesses. We believe that our cash and cash equivalents, short-term investments and cash generated from operations will be sufficient to meet our working capital requirements for at least the next twelve months. We may need to raise additional capital from time to time through the issuance and sale of equity or debt securities, and there is no assurance that we will be able to do so on favorable terms or at all.

As of June 30, 2023, we had no off-balance sheet arrangements.

For additional information related to our Liquidity and Capital Resources, see Note 9 - Debt to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Recent Accounting Pronouncements

See Note 1 - Basis of Presentation and Summary of Significant Accounting Policies to our Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for information about recent accounting pronouncements.

Market risk

As filed, 2,348 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents, short-term investments and our variable rate debt, as well as foreign exchange rate risk.

Interest rate risk. The primary objectives of our investment activity are to preserve principal, provide liquidity and invest excess cash for an average rate of return. To minimize market risk, we maintain our portfolio in cash and diversified investments, which may consist of corporate bonds, bank deposits, money market funds, commercial paper and U.S. Treasury securities. The interest rates are variable and fluctuate with current market conditions. The risk associated with fluctuating interest rates is limited to this investment portfolio. We believe that a 10% change in interest rates would not have a material impact on our financial position or results of operations. We do not enter into financial instruments for trading or speculative purposes.

On August 2, 2023, we paid the total outstanding principal balance on our Term Loans. The interest rates on our 2026 Convertible Notes are fixed and therefore not subject to interest rate risk. For additional information regarding our Term Loans and Convertible Notes, refer to Note 9 - Debt.

Foreign currency risk. To date, our international customer agreements have been denominated primarily in U.S. dollars. Accordingly, we have limited exposure to foreign currency exchange rates. The functional currency of a majority of our foreign operations continues to be in U.S. dollars with the remaining operations being local currency. Changes in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact demand in certain regions, reduce or delay customer orders, or otherwise negatively affect how customers do business with us. The effects of exchange rate fluctuations on the net assets of the majority of our operations are accounted for as transaction gains or losses. We believe that a change of 10% in such foreign currency exchange rates would not have a material impact on our financial position or results of operations. In the future, we may enter into foreign currency exchange hedging contracts to reduce our exposure to changes in exchange rates.

Controls and procedures

As filed, 1,576 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) were effective as of June 30, 2023.

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Controls

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

Risk factors

As filed, 2,451 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business involves a high degree of risk. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2022 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes in any of the risk factors described in our 2022 Annual Report on Form 10-K, except as discussed in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, as filed with the SEC on May 4, 2023, and as noted below.

Adverse global economic conditions could have a negative impact on our business, results of operations and financial condition and liquidity.

A general slowdown in the global economy, including a recession, or in a particular region or industry, an increase in trade tensions with U.S. trading partners, inflation or a tightening of the credit markets could negatively impact our business, financial condition and liquidity. Adverse global economic conditions have, from time to time, caused or exacerbated significant slowdowns in the industries and markets in which we operate, which have adversely affected our business and results of operations. Geopolitical issues, macroeconomic weakness and uncertainty also make it more difficult for us to accurately forecast revenue, gross margin and expenses. An escalation of trade tensions between the U.S. and China has resulted in trade restrictions and increased tariffs that harm our ability to participate in Chinese markets or compete effectively with Chinese companies. Sustained uncertainty about, or worsening of, current global economic conditions and further escalation of trade tensions between the U.S. and its trading partners could result in a global economic slowdown and long-term changes to global trade. Such events may also (i) cause our customers and consumers to reduce, delay or forgo technology spending, (ii) result in customers sourcing products from other suppliers not subject to such restrictions or tariffs, (iii) lead to the insolvency or consolidation of key suppliers and customers and (iv) intensify pricing pressures. Any or all of these factors could negatively affect demand for our products and our business, financial condition and results of operations.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-04-01 to 2023-06-30$148.5mus-gaap:Revenues
Revenue9 months2022-10-01 to 2023-06-30$498.0mus-gaap:Revenues
Cost of revenue3 months2023-04-01 to 2023-06-30$62.4mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-10-01 to 2023-06-30$198.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-04-01 to 2023-06-30$86.1mus-gaap:GrossProfit
Gross profit9 months2022-10-01 to 2023-06-30$299.2mus-gaap:GrossProfit
Research and development3 months2023-04-01 to 2023-06-30$36.7mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2022-10-01 to 2023-06-30$111.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2023-04-01 to 2023-06-30$32.2mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-10-01 to 2023-06-30$96.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-04-01 to 2023-06-30$17.3mus-gaap:OperatingIncomeLoss
Operating income9 months2022-10-01 to 2023-06-30$91.8mus-gaap:OperatingIncomeLoss
Income tax3 months2023-04-01 to 2023-06-30$7.8mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-10-01 to 2023-06-30$29.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-04-01 to 2023-06-30$11.9mus-gaap:NetIncomeLoss
Net income9 months2022-10-01 to 2023-06-30$67.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-04-01 to 2023-06-30$0.17us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-10-01 to 2023-06-30$0.94us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-04-01 to 2023-06-30$0.17us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-10-01 to 2023-06-30$0.95us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-04-01 to 2023-06-3071,408,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-10-01 to 2023-06-3071,395,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-10-01 to 2023-06-30$116.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-10-01 to 2023-06-30$18.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2022-10-01 to 2023-06-30$32.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-06-30$121.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-06-30$852.1mus-gaap:AssetsCurrent
Total assetsAt period end2023-06-30$1.64bnus-gaap:Assets
Current liabilitiesAt period end2023-06-30$210.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-06-30$728.0mus-gaap:Liabilities
Long-term debtAt period end2023-06-30$446.8mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-06-30$120.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-06-30$914.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493594-23-000057. Last ingested by Listed: Nov 14, 2026, 22:08 ET. Listed shows no prices and gives no investment advice.